Albumin-functionality-test
Commercial- Indications
- Cancer, Liver diseases, Kidney diseases, Sepsis
Company intelligence / Profile preview
MedInnovation
Berlin, Berlin, Germanymedinnovation.de ↗
- Ownership
- Private
- Employees
- ~8
- Development stage
- Commercial
01
Overview
The Albumin Functionality Test is a patented blood test using ESR spectroscopy to detect active tumor growth, monitor therapy outcomes in oncology, assess relapse risk, and evaluate albumin function in liver disease/sepsis. Ongoing clinical studies are validating its performance in early cancer detection.
- Therapeutic areas
- OncologyGastroenterologyInfectious Diseases
- Modalities
- Diagnostic PlatformIn Vitro DiagnosticsProtein Analysis (Electron Spin Resonance Spectroscopy)
- Industry
- Protein Biomarker Diagnostics
02
Drug pipeline
1 assetBeyond the preview
Go deeper on MedInnovation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MedInnovation.